The inhibition of neuronal calcium ion channels by trace levels of yttrium released from carbon nanotubes.
Carbon nanotubes (CNTs) are used with increasing frequency in neuroengineering applications. CNT scaffolds are used to transmit electrical stimulation to cultured neurons and to control outgrowth and branching patterns of neurites. CNTs have been reported to disrupt normal neuronal function including alterations in endocytotic capability and inhibition of ion channels. Calcium ion channels regulate numerous neuronal and cellular functions including endo and exocytosis, neurite outgrowth, and gene expression. Strong CNT interactions with neuronal calcium ion channels would have profound biological implications. Here we show that physiological solutions containing CNTs inhibit neuronal voltage-gated calcium ion channels in a dose-dependent and CNT sample-dependent manner with IC50 as low as 1.2 microg/ml. Importantly, we demonstrate that the inhibitory activity does not involve tubular graphene as previously reported, but rather very low concentrations of soluble yttrium released from the nanotube growth catalyst. Cationic yttrium potently inhibits calcium ion channel function with an inhibitory efficacy, IC50, of 0.07 ppm w/w. Because of this potency, unpurified and even some reportedly "purified" CNT samples contain sufficient bioavailable yttrium to inhibit channel function. Our results have important implications for emerging nano-neurotechnology and highlight the critical role that trace components can play in the biological response to complex nanomaterials.
Jakubek
Lorin M
LM
Division of Engineering, Brown University, Providence, RI 02912, USA.
Marangoudakis
Spiro
S
Raingo
Jesica
J
Liu
Xinyuan
X
Lipscombe
Diane
D
Hurt
Robert H
RH
D015220:Calcium Channels / Q000187:drug effects*; D002460:Cell Line; D006801:Humans; D046529:Microscopy, Electron, Transmission; D037742:Nanotubes, Carbon / Q000737:chemistry* / Q000648:ultrastructure; D009532:Nickel / Q000009:adverse effects; D015019:Yttrium / Q000494:pharmacology*
D015220:Calcium Channels; D037742:Nanotubes, Carbon; D015019:Yttrium; D009532:Nickel
J Gen Physiol. 1984 Jun;83(6):941-67
6330284
J Physiol. 1993 Sep;469:639-52
8271221
Annu Rev Physiol. 2003;65:133-59
12471162
J Neurosci. 2007 Jun 27;27(26):6931-6
17596441
Neuron. 1997 Jan;18(1):153-66
9010213
Small. 2008 Jun;4(6):721-7
18504717
Nanotechnology. 2008 May 7;19(18):185706
21825702
J Mol Neurosci. 2000 Jun;14(3):175-82
10984193
Environ Health Perspect. 2005 Jul;113(7):823-39
16002369
Nat Nanotechnol. 2008 Jul;3(7):434-9
18654569
Neuron. 2008 Sep 25;59(6):882-901
18817729
Nature. 2006 Jul 13;442(7099):164-71
16838014
Nat Nanotechnol. 2009 Feb;4(2):126-33
19197316
Nanomedicine (Lond). 2008 Apr;3(2):183-99
18373425
Nanotechnology. 2008 Jan 9;19(1):015101
21730521
J Biol Chem. 2003 Dec 12;278(50):50212-6
14522977
Carbon N Y. 2008 Mar;46(3):489-500
19255622
Nano Lett. 2006 Jun;6(6):1261-8
16771591
Nano Lett. 2004 Mar;4(3):507-511
21394241
Nat Neurosci. 2007 Mar;10(3):285-92
17293861
Nano Lett. 2005 Jun;5(6):1107-10
15943451
J Membr Biol. 2002 Jun 1;187(3):225-38
12163980
J Nanosci Nanotechnol. 2005 Oct;5(10):1707-12
16245532
Nat Rev Drug Discov. 2008 Apr;7(4):358-68
18356919
Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5675-9
15060274
Toxicol Lett. 2007 Jan 10;168(1):58-74
17141434
J Neurophysiol. 2004 Nov;92(5):2820-30
15201306
Toxicol Lett. 2006 Aug 1;165(1):88-100
16527436
Nano Lett. 2008 Oct;8(10):3538-42
18759491